Analystreport

X4 Pharmaceuticals, Inc. (NASDAQ: XFOR) had its price target raised by analysts at Stifel Nicolaus from $4.00 to $5.00.

X4 Pharmaceuticals, Inc.  (XFOR) 
Last x4 pharmaceuticals, inc. earnings: 3/12 07:30 am Check Earnings Report